NEW YORK (GenomeWeb News) - Indian clinical research organization Synchron Research Services has acquired from Parexel a biomarker and bioanalytical research facility based in France for around $6.7 million, Synchron said today.
 
The lab, which is located in Poitiers, France, and was bought by Parexel in 1999, will now be called Synexel Research International. The lab offers singleplexed and multiplexed immunoassay platforms that support early clinical, pre-clinical, and clinical studies, as well as biomarker research programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.